Patent · US Active

Substituted piperazines as CB1 antagonists

US7700597B2 · kind B2 · utility

3Cited by

34References

50Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Eric J. Gilbert · Scotch Plains, US
Michael Miller · Scotch Plains, US
Jack D. Scott · Scotch Plains, US
Andrew Stamford · Madison, US
William J. Greenlee · Teaneck, US
Jay Weinstein · Upper Montclair, US

Key dates

Filing date	Dec 1, 2005
Grant date	Apr 20, 2010
Priority date	—
Expiry date	Nov 27, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of Formula (I):or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.